← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $319K of Karuna Therapeutics, Inc.

Sold$319,325
$127.73Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Wed, Dec 1. Filed Thu, Dec 2, 5:21 PM ET, after the close. Not investment advice.